a b c d e f g h i j k l m n o p q r s t u v w x y z #

Plasma Products Lot Release Certificates

 

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2X018AL

  • Date of Issuance: 25-Nov-22

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2X023AP

  • Date of Issuance: 30-Jan-23

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2X038AB

  • Date of Issuance: 22-Feb-23

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent F2V057AP

  • Date of Issuance: 16-Apr-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent F2W001AM

  • Date of Issuance: 12-Jul-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent F2W014AA

  • Date of Issuance: 12-Jul-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 1000U F2T084AE

  • Date of Issuance: 11-Apr-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 1000U F2U017AS

  • Date of Issuance: 28-Aug-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 1000U F2U024BAH

  • Date of Issuance: 28-Aug-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 1000U F2W001AM

  • Date of Issuance: 12-Jul-21

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2U017AD

  • Date of Issuance: 20-Jun-19

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2S087AF

  • Date of Issuance: 1-Aug-18

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2T053AB

  • Date of Issuance: 7-Nov-18

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2T053AN

  • Date of Issuance: 16-Nov-18

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent for solution for intravenous injection 500U F2T053AN

  • Date of Issuance: 16-Nov-18
<<  23 24 25 26 27 [2829 30 31 32  >>  

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

Image   Image   Image   Image  

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Selasa 07 Mei 2024, 15:09:17.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Menu Utama